Fauziya Naikar: Why the MTHFR Gene is a Critical Piece of the Fertility Puzzle
Fauziya Naikar, Junior Embryologist at Star IVF and Fertility Center, shared a post on LinkedIn:
“Why the MTHFR Gene is a Critical Piece of the Fertility Puzzle?
In the embryology lab, we spend our days perfecting morphokinetics and grading.
But beyond the petri dish, a ‘silent architect’ is at work: the MTHFR (Methylenetetrahydrofolate Reductase) gene.
Why do high-quality embryos sometimes fail to result in a live birth?
The answer often lies in the biochemical environment provided by parental genetics—specifically the methylation pathway.
The Molecular Breakdown.
The MTHFR enzyme is the critical rate-limiting step in the folate cycle.
Its primary job is to catalyze the conversion of folate into 5-methyltetrahydrofolate (5-MTHF).
This active form is the ‘fuel’ for two vital processes:
- DNA Methylation: This is the cornerstone of epigenetic programming during early cleavage stages. Without it, cellular repair and gene expression are compromised.
- Homocysteine Regulation: MTHFR converts homocysteine into methionine. When mutations like C677T or A1298C occur, enzyme efficiency can drop by 30 percent to 70 percent, causing homocysteine levels to spike.
The Embryologist’s Perspective: Why It Matters?
We see the effort it takes to create a viable embryo, but that embryo needs a stable environment to thrive post-transfer.
Elevated homocysteine (Hyperhomocysteinemia) is a known risk factor for micro-clots in the placental vasculature (Thrombophilia).
This can lead to:
- Implantation failure or early pregnancy loss.
- Neural tube defects (Spina Bifida, Anencephaly).
- Impaired blood flow to the uterus and placenta.
Clinical Pivot: From ‘Unexplained’ to ‘Targeted’.
The traditional reliance on synthetic Folic Acid may not be enough for patients with these genetic variants, as their bodies cannot efficiently convert it.
The Solution?
Bypassing the genetic ‘roadblock’ by using bioavailable Methylfolate (5-MTHF) along with Vitamins B6 and B12.
This targeted approach lowers homocysteine and optimizes the metabolic environment for the embryos we work so hard to cultivate.
By understanding these genomic markers, we move away from the frustration of ‘unexplained infertility’ and toward a more precise, personalized fertility protocol.
Stay updated with Hemostasis Today.
-
Jun 24, 2026, 03:36Ana Pedrero Gil: A New Approach to Post-Tonsillectomy Hemorrhage
-
Jun 24, 2026, 02:59Melissa Hollo: Making Early Anemia Detection the Standard of Care
-
Jun 24, 2026, 02:51Bruno Pougault: The Thin Line Between Bleeding and Clotting
-
Jun 23, 2026, 23:30Shunsuke Iwano: PMDA Introduces Greater Flexibility for Pediatric Factor VIII and IX Development in Japan
-
Jun 23, 2026, 23:05Rounak Dubey: ISBT Academy Session on Agentic AI
-
Jun 23, 2026, 22:59Mohammed Maher Babiker: When ‘Low Platelets’ aren’t Really Low
-
Jun 23, 2026, 22:49Giovanni Merlino: Why Does Stress Hyperglycemia Worsen Stroke Outcomes?
-
Jun 23, 2026, 22:41Tareq Abadl: Coombs Test – The Key to Detecting Immune-Mediated Hemolysis
-
Jun 23, 2026, 22:32How WFH Impacted the Bleeding Disorders Community in 2025